| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.35 | 0.01 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.31 | 0.02 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |